Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

Blood (2018) 131 (23): 2541–2551.

https://doi.org/10.1182/blood-2017-11-814608

Published: 2018

Includes: Supplemental data

Journal Articles

Progression to AML Is Predictable and Distinct from Age Related Clonal Hematopoiesis

Sagi Abelson, PhD, Stanley W.K. Ng, Omer Wiessbrod, Philip Zuzarte, Lawrence Heisler, Yogi Sundaravadanam, Ting Ting Wang, Trevor J. Pugh, PhD, David Soave, Paul Brennan, Mattias Johansson, Phillip Awadalla, Scott V. Bratman, Jean Wang, MD PhD, Mark D. Minden, MD PhD, John E. Dick, PhD, Liran I. Shlush

Blood (2017) 130 (Supplement 1): 471.

https://doi.org/10.1182/blood.V130.Suppl_1.471.471

Published: 2017

Journal Articles

CXCL12 Enhances CLL Cell and T-Cell Migration in a Dynamic Circulating Model of CLL That Can be Abrogated By the CXCR4 Antagonist ONO-7161

Elisabeth J Walsby, Paul Brennan, Guy Pratt, Tanja Nicole Hartmann, PhD, Toshio Yoshizawa, Christopher Fegan, Chris Pepper

Blood (2014) 124 (21): 3293.

https://doi.org/10.1182/blood.V124.21.3293.3293

Published: 2014

Journal Articles

Mitochondrial DNA copy number and future risk of B-cell lymphoma in a nested case-control study in the prospective EPIC cohort

Blood (2014) 124 (4): 530–535.

https://doi.org/10.1182/blood-2013-10-532085

Published: 2014

Includes: Supplemental data

Journal Articles

Development and characterization of a physiologically relevant model of lymphocyte migration in chronic lymphocytic leukemia

Elisabeth Walsby, Andrea Buggins, Stephen Devereux, Ceri Jones, Guy Pratt, Paul Brennan, Chris Fegan, Chris Pepper

Blood (2014) 123 (23): 3607–3617.

https://doi.org/10.1182/blood-2013-12-544569

Published: 2014

Includes: Supplemental data

Journal Articles

A Meta-Analysis Of Hodgkin Lymphoma Reveals 19p13.3 (TCF3) As a Novel Susceptibility Loc

Wendy Cozen, D.O., M.P.H., Dalin Li, M.D., Ph.D., Maria Timofeeva, Ph.D., Arjan Diepstra, MD PhD, Dennis Hazelett, Ph.D., Manon Delahaye-Sourdeix, M.S., Christopher K. Edlund, M.S., Klaus Rostgaard, Ph.D., David J. Van Den Berg, Ph.D., Lude Franke, Ph.D., Karin Eckstrom Smedby, M.D., Ph.D., Sally L. Glaser, Ph.D., Harm-Jam Westra, Ph.D., Leslie L. Robison, PhD, Thomas M. Mack, M.D., M.P.H., Herve Ghesquieres, MD, PhD, Amie E. Hwang, Ph.D., M.P.H., Alexandra Nieters, Ph.D., Silvia de Sanjosé, M.D., Ph.D., Victoria K. Cortessis, Ph.D., Tracy Lightfoot, Nikolaus Becker, M.D., Ph.D., Marc Maynadie, MD, PhD, Lenka Foretova, Ph.D., Eve Roman, Ph.D., Yolanda Benavente, Ph.D., Bharat N. Nathwani, M.D., Bengt Glimelius, M.D., Ph.D., Anthony Staines, M.D., Ph.D., Paolo Boffetta, M.D., M.P.H., Brian K Link, MD, L. A. Kiemeney, Ph.D., Stephen M Ansell, M.D.Ph.D., Smita Bhatia, Ph.D., Louise C Strong, Ph.D., Pilar Galan, M.D., Lars Vatten, M.D., Ph.D., Thomas M Habermann, MD, Eric J. Duell, Ph.D., M.S., Annette Lake, M.S., Rianne Veenstra, Lydia Visser, PhD, Kevin Urayama, Ph.D., Dorothy Montgomery, Valerie Gaborieau, Lawrence Weiss, M.D, Graham Byrnes, Ph.D., Mark Lathrop, PhD, Hans-Olov Adami, M.D., Ph.D., Mads Melbye, MD, DMSc, James R Cerhan, MD, PhD, Alice Gallagher, M.D., G. Malcolm Taylor, MD, Susan L Slager, PhD, Paul Brennan, Ph.D., David V. Conti, Ph.D., Gerhard Coetzee, Ph.D., Kenan Onel, MD, PhD, Ruth F. Jarrett, M.D., Ph.D., Henrik Hjalgrim, M.D., Ph.D., Anke Van Den Berg, PhD, James D. McKay, Ph.D.

Blood (2013) 122 (21): 626.

https://doi.org/10.1182/blood.V122.21.626.626

Published: 2013

Journal Articles

Characterization Of a Novel In Vitro Circulation System Designed To Model The Migration Of Primary CLL Cells Across The Vascular Endothelium

Elisabeth J Walsby, Andrea GS Buggins, Ph.D., Stephen Devereux, FRCP, FRCPath, PhD, Paul Brennan, Chris Fegan, Chris Pepper

Blood (2013) 122 (21): 667.

https://doi.org/10.1182/blood.V122.21.667.667

Published: 2013

Journal Articles

Exposure to UV radiation and risk of Hodgkin lymphoma: a pooled analysis

Alain Monnereau, Sally L. Glaser, Clayton W. Schupp, Karin Ekström Smedby, Silvia de Sanjosé, Eleanor Kane, Mads Melbye, Lenka Forétova, Marc Maynadié, Anthony Staines, Nikolaus Becker, Alexandra Nieters, Paul Brennan, Paolo Boffetta, Pierluigi Cocco, Ingrid Glimelius, Jacqueline Clavel, Henrik Hjalgrim, Ellen T. Chang

Blood (2013) 122 (20): 3492–3499.

https://doi.org/10.1182/blood-2013-04-497586

Published: 2013

Journal Articles

PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium

Blood (2012) 120 (23): 4645–4648.

https://doi.org/10.1182/blood-2012-05-427989

Published: 2012

Includes: Supplemental data

Journal Articles

HLA-DP genetic variation, proxies for early life immune modulation and childhood acute lymphoblastic leukemia risk

Kevin Y. Urayama, Anand P. Chokkalingam, Catherine Metayer, Xiaomei Ma, Steve Selvin, Lisa F. Barcellos, Joseph L. Wiemels, John K. Wiencke, Malcolm Taylor, Paul Brennan, Gary V. Dahl, Priscilla Moonsamy, Henry A. Erlich, Elizabeth Trachtenberg, Patricia A. Buffler

Blood (2012) 120 (15): 3039–3047.

https://doi.org/10.1182/blood-2012-01-404723

Published: 2012

Journal Articles

Two Distinct Co-Culture Systems, Designed to Mimic the Tumor Microenvironment, Induce Remarkably Similar Phenotypic Changes in Primary CLL Cells.

Andrea Gail Sherman Buggins, Ph.D., Laurence Pearce, B.Sc, Piers EM Patten, BSc, MRCP, MRCPath, Liam Morgan, Paul Brennan, Chris Fegan, Stephen Devereux, FRCP, FRCPath, Chris J Pepper

Blood (2009) 114 (22): 2362.

https://doi.org/10.1182/blood.V114.22.2362.2362

Published: 2009

Journal Articles

Rel a Is a Novel Prognostic Marker in CLL That Is Independent of V H Gene Mutation Status, CD38 Expression and ZAP-70 Expression

Saman Hewamana, Thet Thet Lin, Clare Rowntree, Kamaraj Karunanithi, Alan Burnett, Paul Brennan, Chris Fegan, Chris Pepper

Blood (2008) 112 (11): 4153.

https://doi.org/10.1182/blood.V112.11.4153.4153

Published: 2008

Journal Articles

Pharmacological Inhibition of NF-KB Underpins the Strong Synergy Between LC-1 and Fludarabine in Chronic Lymphocytic Leukaemia Cells

Saman Hewamana, Thet Thet Lin, Chris Fegan, Steven Knapper, Alan Burnett, Paul Brennan, Clare Rowntree, Chris Pepper

Blood (2008) 112 (11): 380.

https://doi.org/10.1182/blood.V112.11.380.380

Published: 2008

Journal Articles

Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers

Chris Pepper, Thet Thet Lin, Guy Pratt, Saman Hewamana, Paul Brennan, Louise Hiller, Robert Hills, Rachel Ward, Jane Starczynski, Belinda Austen, Laura Hooper, Tatjana Stankovic, Chris Fegan

Blood (2008) 112 (9): 3807–3817.

https://doi.org/10.1182/blood-2008-05-157131

Published: 2008

Includes: Supplemental data

Journal Articles

The NF-κB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target

Saman Hewamana, Suhair Alghazal, Thet Thet Lin, Matthew Clement, Chris Jenkins, Monica L. Guzman, Craig T. Jordan, Sundar Neelakantan, Peter A. Crooks, Alan K. Burnett, Guy Pratt, Chris Fegan, Clare Rowntree, Paul Brennan, Chris Pepper

Blood (2008) 111 (9): 4681–4689.

https://doi.org/10.1182/blood-2007-11-125278

Published: 2008

Journal Articles

Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium

Blood (2008) 111 (8): 4029–4038.

https://doi.org/10.1182/blood-2007-10-119974

Published: 2008

Includes: Supplemental data

Journal Articles

Transcription Factor NF-kB as a Biomarker for Disease Progression and Target for Treatment in Chronic Lymphocytic Leukaemia.

Saman Hewamana, MRCP, MRCPath, Mathew Clement, BSc, Thet Thet Lin, PhD, Chris Jenkins, MRCP, Chris Fegan, FRCP,FRCPath,MD, Clare Rowntree, FRCP,MRCPath,PhD, Paul Brennan, PhD, Chris Pepper, PhD

Blood (2007) 110 (11): 3091.

https://doi.org/10.1182/blood.V110.11.3091.3091

Published: 2007

Journal Articles

Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph)

Blood (2006) 109 (8): 3479–3488.

https://doi.org/10.1182/blood-2006-06-031948

Published: 2006

Journal Articles

CD21 Expression Is Inversely Correlated with the Ability of CLL Cells To Induce Tyrosine Phosphorylation in Response to Anti-IgM.

Chris Pepper, PhD, Suhair Alghazal, MD, Paul Brennan, PhD, Clare Rowntree, MB, PhD, Thet Thet Lin, PhD, Guy Pratt, MD, Chris Fegan, MD

Blood (2006) 108 (11): 2806.

https://doi.org/10.1182/blood.V108.11.2806.2806

Published: 2006

Journal Articles

Variation in DNA Repair Genes XRCC3, XRCC4, and XRCC5 and Risk of Myeloma.

Patrick Hayden, MD, Prerna Tewari, PhD, Anthony Staines, MD, Derek Morris, PhD, Dominique Crowley, MD, Alexandra Nieters, PhD, Nicholas Becker, MD, Silvia de Sanjose, MD, L. Foretova, MD, Mark Maynardie, MD, Pier Luigi Coco, MD, Paolo Boefetta, PhD, Paul Brennan, PhD, Paul V. Browne, MD, Mark Lawler, PhD

Blood (2006) 108 (11): 3416.

https://doi.org/10.1182/blood.V108.11.3416.3416

Published: 2006

NARROW

Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

Progression to AML Is Predictable and Distinct from Age Related Clonal Hematopoiesis

CXCL12 Enhances CLL Cell and T-Cell Migration in a Dynamic Circulating Model of CLL That Can be Abrogated By the CXCR4 Antagonist ONO-7161

Mitochondrial DNA copy number and future risk of B-cell lymphoma in a nested case-control study in the prospective EPIC cohort

Development and characterization of a physiologically relevant model of lymphocyte migration in chronic lymphocytic leukemia

A Meta-Analysis Of Hodgkin Lymphoma Reveals 19p13.3 (TCF3) As a Novel Susceptibility Loc

Characterization Of a Novel In Vitro Circulation System Designed To Model The Migration Of Primary CLL Cells Across The Vascular Endothelium

Exposure to UV radiation and risk of Hodgkin lymphoma: a pooled analysis

PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium

HLA-DP genetic variation, proxies for early life immune modulation and childhood acute lymphoblastic leukemia risk

Two Distinct Co-Culture Systems, Designed to Mimic the Tumor Microenvironment, Induce Remarkably Similar Phenotypic Changes in Primary CLL Cells.

Rel a Is a Novel Prognostic Marker in CLL That Is Independent of V H Gene Mutation Status, CD38 Expression and ZAP-70 Expression

Pharmacological Inhibition of NF-KB Underpins the Strong Synergy Between LC-1 and Fludarabine in Chronic Lymphocytic Leukaemia Cells

Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers

The NF-κB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target

Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium

Transcription Factor NF-kB as a Biomarker for Disease Progression and Target for Treatment in Chronic Lymphocytic Leukaemia.

Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph)

CD21 Expression Is Inversely Correlated with the Ability of CLL Cells To Induce Tyrosine Phosphorylation in Response to Anti-IgM.

Variation in DNA Repair Genes XRCC3, XRCC4, and XRCC5 and Risk of Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only